September 20, 2008 – OptiNose presents clinical data on the treatment of nasal polyposis as an oral presentation during the 2008 American Rhinology Society Annual Fall Meeting on 20 September 2008 in Chicago.
Presentation: Fluticasone Propionate Delivered with a Novel Breath Actuated Bi-directional Nasal Device is Highly Efficient in Treating Nasal Polyps and Associated Symptoms
– Per Gisle Djupesland, MD, PhD, Tony Flint, PhD, Colin Sheldrake, PhD, Ingrid Vickova, MD, PhD
For more information, contact us.